Previous
Previous

ImmTune Therapies is one of the top 3 finalists for Merck’s emerging biotechs grant programme, aimed at supporting young biotechs with Merck’s expertise.

Next
Next

ImmTune Therapies wins the audience choice award at Bio Europe 2020.